Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in Neuroblastoma

1 Apr 2018

Abstract excerpt

Abstract Background Current clinical risk factors stratify patients with neuroblastoma (NB) for appropriate treatments, yet patients with similar clinical behaviors evoke variable responses. MYCN amplification is one of the established drivers of NB and, when combined with high-risk displays, worsens outcomes. Growing high-throughput transcriptomics studies suggest long noncoding RNA (lncRNA) dysregulation in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer-related molecular mechanisms research
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31360848
DOI: 10.1093/jncics/pky015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in NeuroblastomaPMID 31360848Read ↗

The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.Semantic proximity Read ↗

Genetic discoveries and treatment advances in neuroblastoma.Semantic proximity Read ↗

Bioinformatics identification of key genes associated with risk and prognosis of neuroblastomaSemantic proximity Read ↗

Development and Validation of a Lncrnas-Based Nomogram for Survival Prediction in Neuroblastoma PatientsSemantic proximity Read ↗

miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor SamplesSemantic proximity Read ↗

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastomaSemantic proximity Read ↗

Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma.Semantic proximity Read ↗

Role of long noncoding RNA in neuroblastoma.Semantic proximity Read ↗

Identification of novel prognostic markers of survival time in high-risk neuroblastoma using gene expression profilesSemantic proximity Read ↗

Co-expression analysis identifies long noncoding RNA <i>SNHG1</i> as a novel predictor for event-free survival in neuroblastomaSemantic proximity Read ↗

A Three-Gene Expression Signature Model for Risk Stratification of Patients with NeuroblastomaSemantic proximity Read ↗

Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.